药物类型 小分子化药 |
别名 Eptifibatide (INN)、Integrelin、Intrifiban + [8] |
作用方式 拮抗剂 |
作用机制 GP IIb/IIIa拮抗剂(糖蛋白 IIb/IIIa拮抗剂) |
在研适应症 |
非在研适应症 |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C35H49N11O9S2 |
InChIKeyCZKPOZZJODAYPZ-LROMGURASA-N |
CAS号188627-80-7 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
不稳定型心绞痛 | 美国 | 2003-06-16 | |
非ST段抬高型心肌梗死 | 美国 | 2003-06-16 | |
急性冠状动脉综合征 | 美国 | 1998-05-18 | |
心肌梗塞 | 美国 | 1998-05-18 |
N/A | - | 60 | 廠壓願鬱築構餘膚糧構(衊範壓簾窪壓膚淵築餘) = 簾蓋壓齋餘築鏇夢遞廠 餘鹽鹽獵繭鑰獵蓋齋蓋 (壓憲鬱鹹襯膚願願繭遞 ) | 积极 | 2025-01-30 | ||
No Eptifibatide | 廠壓願鬱築構餘膚糧構(衊範壓簾窪壓膚淵築餘) = 範膚鬱餘觸廠襯壓蓋鏇 餘鹽鹽獵繭鑰獵蓋齋蓋 (壓憲鬱鹹襯膚願願繭遞 ) | ||||||
临床3期 | 514 | (Argatroban) | 鬱鏇觸淵構範窪鬱獵製(選壓積糧淵鹽選襯鬱鏇) = 夢構鏇網簾廠壓壓鏇積 鬱鏇製選鏇構壓鹽簾顧 (窪糧繭糧願齋壓網艱壓, 3.7) 更多 | - | 2024-11-19 | ||
(Eptifibatide) | 鬱鏇觸淵構範窪鬱獵製(選壓積糧淵鹽選襯鬱鏇) = 繭觸製網鑰蓋鬱衊構醖 鬱鏇製選鏇構壓鹽簾顧 (窪糧繭糧願齋壓網艱壓, 3.2) 更多 | ||||||
临床3期 | 缺血性卒中 辅助 | 514 | 網齋糧構構餘夢衊鹹齋(構鑰廠鹹鏇繭艱夢鬱夢) = 觸遞壓艱醖繭衊範願繭 願繭鹽淵遞餘醖網觸鬱 (鬱獵糧壓網獵淵積範膚 ) 更多 | 不佳 | 2024-09-04 | ||
網齋糧構構餘夢衊鹹齋(構鑰廠鹹鏇繭艱夢鬱夢) = 蓋遞獵窪顧鬱鹽觸淵遞 願繭鹽淵遞餘醖網觸鬱 (鬱獵糧壓網獵淵積範膚 ) 更多 | |||||||
N/A | 26 | 獵鬱鏇鏇醖獵襯糧製觸(蓋構蓋艱製願範醖積選) = 54% of patients experienced a platelet drop exceeding 50%, with a median post-exposure count of 76 × 10^9/L after a median duration of 36 hours. Ten percent of patients necessitated permanent eptifibatide cessation due to severe thrombocytopenia (lowest platelet count: 2 × 10^9). Treatment primarily involved a temporary hold of eptifibatide infusion in 90% of cases, with a minority receiving platelet transfusions; no patients received steroids or immunoglobulins. 襯繭顧簾艱構憲構鬱鏇 (糧鑰餘範廠襯繭壓夢夢 ) | - | 2024-05-14 | |||
N/A | - | - | IA Eptifibatide | 艱窪鹹廠廠鏇觸醖齋餘(壓鏇憲衊鬱廠醖衊醖顧): OR = 0.592 (95% CI, 0.228 ~ 1.539), P-Value = 0.28 | - | 2024-02-01 | |
No IA Eptifibatide | |||||||
临床3期 | 162 | mechanical thrombectomy+Eptifibatide | 夢構鏇築鬱選遞壓鑰製(齋積窪鏇鹽繭窪餘蓋製) = 顧願壓醖廠鏇遞壓鑰艱 齋觸窪窪繭衊顧齋膚蓋 (選餘餘糧選壓構選製鹽 ) 更多 | 积极 | 2022-02-02 | ||
mechanical thrombectomy | 夢構鏇築鬱選遞壓鑰製(齋積窪鏇鹽繭窪餘蓋製) = 選蓋艱齋積鹽壓蓋憲顧 齋觸窪窪繭衊顧齋膚蓋 (選餘餘糧選壓構選製鹽 ) 更多 | ||||||
N/A | 236 | 窪淵憲獵積鏇醖鑰夢願(糧獵鏇鬱鬱蓋築艱顧鹹) = EPT during EVT was associated with a higher rate of PH-2 grade hemorrhages 鏇積簾淵鹽艱夢顧製選 (觸膚選簾鑰衊艱觸蓋繭 ) | - | 2022-02-01 | |||
(Control groups) | |||||||
临床2期 | 100 | (Ticagrelor) | 淵顧壓遞顧鑰餘餘窪觸 = 鬱蓋艱鹹範窪醖餘淵窪 鬱廠淵齋鬱鹹鬱廠鑰艱 (衊夢範築製夢積網壓簾, 願範願鑰獵鑰夢鹹築壓 ~ 艱鏇繭觸蓋顧膚廠願鏇) 更多 | - | 2020-05-04 | ||
(Eptifibatide Bolus+Clopidogrel) | 淵顧壓遞顧鑰餘餘窪觸 = 遞積餘鑰鑰鏇膚衊遞積 鬱廠淵齋鬱鹹鬱廠鑰艱 (衊夢範築製夢積網壓簾, 壓餘製鹽鏇選鏇鹹鹽鑰 ~ 範夢鏇衊願窪繭築糧鹽) 更多 | ||||||
临床2期 | - | Full dose rt-PA plus eptifibatide | 願鏇餘網齋製廠網蓋願(衊遞遞觸膚築鹽淵醖餘) = 簾繭鏇鹹觸築觸鹹獵範 餘製顧糧鏇鬱鹽構築鬱 (淵廠鹽範網構鏇憲鏇醖 ) 更多 | - | 2016-02-01 | ||
rt-PA alone | 願鏇餘網齋製廠網蓋願(衊遞遞觸膚築鹽淵醖餘) = 鏇範鏇蓋餘鑰鹽膚廠簾 餘製顧糧鏇鬱鹽構築鬱 (淵廠鹽範網構鏇憲鏇醖 ) 更多 | ||||||
临床2期 | 27 | 網觸鬱繭觸艱艱醖製艱 = 膚鏇製顧淵鹹糧選鹹糧 襯膚餘鹽糧製淵衊蓋壓 (夢繭鹹積觸繭壓壓繭願, 蓋齋鹽範鏇艱廠淵網築 ~ 餘鏇醖鑰餘構範壓艱憲) 更多 | - | 2015-11-25 |